Clinical

Standardized, product agnostic, and regulatorily-compliant procedures.

Regen Med is both product and protocol agnostic. it partners with leading physicians around the world in the efficient delivery of evidence-based, regulatorily-compliant regenerative medicine procedures. Our Clinical/Scientific Advisory Board and international professional network support partners in the selection and implementation of the clinical approaches most suitable for their patient panels and practice objectives. Properly structured, an RMCE represents a clinical model which provides physicians professional and financial independence, meaningful participation in the advancement of medical science, superior patient-engagement and the platform upon which to build permanent value.

Product Selection and Procurement

We help our partners select, procure, and validate regionally accessible and compliant products and devices.

READ MORE

Focused Circle Sprints

We connect two or more clinicians, with a scientific moderator, for the purpose of designing, sharing and collaborating on clinical protocols or studies.

READ MORE

Protocol Drafting

We help clinical partners compose and then validate pre, peri and post-operative clinical protocols.

READ MORE

Professional Training and Accreditation

We help our partners design, manage and advertise professional educational curriculum.

READ MORE

Our People

William Futrell

Co-Founder

Regen Med

Former Professor and Chief of Plastic Surgery at the University of Pittsburgh Medical Center for 21 years. Dr. Futrell served as a President of the American Association of Plastic Surgeons and multiple other medical organizations and author or co-author of more than 200 peer-reviewed scientific publications.

READ MORE

Peter Johnson

Board Member

Regen Med

Dr. Johnson practiced reconstructive surgery for ten years at U. Pittsburgh where he founded and was the first President of the Pittsburgh Tissue Engineering Initiative.  Subsequent roles were co-founder/CEO of Tissue Informatics, EVP of Life Sciences, CMO and CBO of Icoria, EVP, Entegrion, Inc. and VP, Research and Development and Medical and Scientific Affairs of Vancive Medical Technologies, an Avery Dennison business.

READ MORE

J. Peter Rubin

Board Member

Regen Med

Dr. Rubin is MD, is Chair of the Department of Plastic Surgery and the UPMC Endowed Professor of Plastic Surgery, as well as Professor of Bioengineering. He is a noted expert on adult stem cells derived from fat tissue and advanced reconstructive surgery.

READ MORE